5q缺失骨髓增生异常综合征中严重(输血依赖)贫血的演变以巨噬细胞相关的红系造血龛衰竭为特征
该研究评估39例5q缺失骨髓增生异常综合征(MDS.del(5q))患者,发现93%的贫血进展和70%的外周血血红蛋白绝对值下降归因于红系造血岛消失,且红系造血岛丢失与骨髓巨噬细胞RPS14依赖性改变相关(p < 0.00005)。在小鼠模型中,约70%的红系造血岛丢失与骨髓巨噬细胞RPS14依赖性S100A8过表达相关。显著的红系造血岛丢失预测来那度胺治疗疗效降低(红细胞输血 Independence)(p = 0.0006)。
要点
- 5q缺失MDS患者贫血进展主要归因于红系造血岛消失,而非红系前体细胞RPS14依赖性改变。
- 红系造血岛丢失与骨髓巨噬细胞内在(S100A8+)和外在(TNF-α过 production)改变相关(p < 0.00005)。
- 显著红系造血岛丢失预测来那度胺治疗实现红细胞输血独立的疗效降低(p = 0.0006)。
核心结论
- MDS.del(5q)特征性红系发育低下似乎主要源于巨噬细胞相关的红系造血龛衰竭,显著降低有效红细胞生成能力,是贫血进展和红细胞输血依赖演变的主要因素。
研究设计与样本
- 研究评估了39例MDS.del(5q)患者,并使用RPS14单倍剂量不足小鼠模型。
主要发现
- 在39例MDS.del(5q)患者中,<5%的贫血进展归因于RPS14依赖性的正常红细胞、原红细胞或CD34+ CD71+前体改变。
- 93%的贫血进展和70%的外周血Hb绝对值下降归因于红系造血岛消失。
- 红系造血岛丢失与RPS14依赖性的(CD169+)骨髓巨噬细胞内在(S100A8+)和外在(TNF-α过 production)改变相关(p < 0.00005)。
- 在RPS14单倍剂量不足小鼠模型中,约70%的红系造血岛丢失与骨髓巨噬细胞RPS14依赖性S100A8过表达相关,<20%与CD71high Ter119-未成熟前体相关,<5%与正常红细胞或原红细胞S100A8/p53过表达相关。
- 显著的红系造血岛丢失预测来那度胺治疗实现红细胞输血独立的疗效降低(p = 0.0006)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Evolution of erythrocyte transfusion-dependent (RBC-TD) anaemia associated with haploinsufficiency of the ribosomal protein subunit S14 gene (RPS14) is a characteristic complication of myelodysplastic syndromes (MDS) with del(5q) [MDS.del(5q)]. Evaluating 39 patients with MDS.del(5q), <5% of anaemia progression was attributable to RPS14-dependent alterations of normoblasts, pro-erythroblasts, or CD34+ CD71+ precursors. Ninety-three percent of anaemia progression and 70% of the absolute decline in peripheral blood Hb value were attributable to disappearance of erythroblastic islands (Ery-Is). Ery-Is loss occurred independently of blast excess, TP53 mutation, additional chromosome aberrations and RPS14-dependent alterations of normoblasts and pro-erythroblasts. It was associated with RPS14-dependent intrinsic (S100A8+ ) and extrinsic [tumour necrosis factor α (TNF-α)-overproduction] alterations of (CD169+ ) marrow macrophages (p < 0.00005). In a mouse model of RPS14 haploinsufficiency, Ery-Is disappeared to a similar degree: approximately 70% of Ery-Is loss was related to RPS14-dependent S100A8 overexpression of marrow macrophages, less than 20% to that of CD71high Ter119- immature precursors, and less than 5% to S100A8/p53 overexpression of normoblasts or pro-erythroblasts. Marked Ery-Is loss predicted reduced efficacy (erythrocyte transfusion independence) of lenalidomide therapy (p = 0.0006). Thus, erythroid hypoplasia, a characteristic complication of MDS.del(5q), seems to result primarily from a macrophage-associated failure of the erythropoietic niche markedly reducing the productive capacity of erythropoiesis as the leading factor in anaemia progression and evolution of RBC-TD in MDS.del(5q).
引用
- Buesche G, Teoman H, Schneider RK, et al. Evolution of severe (transfusion-dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage-associated failure of the eythropoietic niche. Br J Haematol. 2022. PMID: 35362549. doi:10.1111/bjh.18163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。